Abstract

BackgroundPenile squamous cell carcinoma (pSCC) is a rare and aggressive neoplasm with poor outcomes in advanced settings and limited treatment options beyond TIP chemotherapy (paclitaxel/ifosfamide/cisplatin). We evaluated real-world outcomes in...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call